Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (2): 203-208.doi: 10.3736/jcim20080220

• Literature Review • Previous Articles     Next Articles

Progress of integrative medicine, human papillomavirus vaccine and molecular targeted therapy for cervical cancer

Chi-shing Cho()   

  1. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
  • Received:2007-08-17 Online:2008-02-20 Published:2008-02-15
  • Contact: CHO Chi-shing E-mail:chocs@ha.org.hk

Key words: cervical cancer, human papillomavirus, vaccines, diagnosis, therapy, integrated Chinese traditional and Western medicine therapy

CLC Number: 

  • R737.3
[1] Feeley C . Advances in cervical cancer screening and human papillomavirus vaccines. J Br Menopause Soc. 2006; 12(1):19-23.
doi: 10.1258/136218006775997252 pmid: 16513018
[2] Parkin DM, Bray F, Ferlay J , et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108.
[3] Doorbar J . Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006; 110(5):525-541.
doi: 10.1042/CS20050369
[4] Martin CM, Astbury K , O'Leary JJ. Molecular profiling of cervical neoplasia. Expert Rev Mol Diagn. 2006 ; 6(2):217-229.
doi: 10.1586/14737159.6.2.217 pmid: 16512781
[5] Haverkos HW . Multifactorial etiology of cervical cancer: a hypothesis. MedGenMed. 2005; 7(4) : 57.
pmid: 16614679
[6] Danaei G, Vander Hoorn S, Lopez AD , et al. Causes of cancer in the world : comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005; 366(9499):1784-1793.
doi: 10.1016/S0140-6736(05)67725-2
[7] International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors : Collaborative reanalysis of individual data on 16, 563 women with cervical carcinoma and 33, 542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer. 2006; 119(5):1108-1124.
[8] Rieck G, Fiander A . The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol. 2006; 20(2):227-251.
doi: 10.1016/j.bpobgyn.2005.10.010 pmid: 16543119
[9] Valdespino VM, Valdespino VE . Cervical cancer screening : state of the art. Curr Opin Obstet Gynecol. 2006; 18(1):35-40.
doi: 10.1097/01.gco.0000192971.59943.89 pmid: 16493258
[10] Zeferino LC, Derchain SF . Cervical cancer in the developing world. Best Pract Res Clin Obstet Gynaecol. 2006; 20(3):339-354.
doi: 10.1016/j.bpobgyn.2006.01.018 pmid: 11577044
[11] Calloway C, Jorgensen CM, Saraiya M , et al. A content analysis of news coverage of the HPV vaccine by U. S. newspapers,January 2002-June 2005. J Womens Health (Larchmt). 2006; 15(7):803-809.
doi: 10.1089/jwh.2006.15.803
[12] Ljubojevic S . The human papillomavirus vaccines. Acta Dermatovenerol Croat. 2006; 14(3):208.
[13] Hanna E, Bachmann G . HPV vaccination with Garda- sil : a breakthrough in womens health. Expert Opin Biol Ther. 2006; 6(11):1223-1227.
doi: 10.1517/14712598.6.11.1223
[14] McLemore MR . Gardasil: Introducing the new human papillomavirus vaccine. Clin J Oncol Nurs. 2006; 10(5):559-560.
doi: 10.1188/06.CJON.559-560 pmid: 17063609
[15] HPV vaccine fights cervical cancer. CA Cancer J Clin. 2006; 56(5):249-250.
[16] Prandi S, Beccati D, De Aloysio G , et al. Applicability of the Bethesda System 2001 to a public health setting. Cancer. 2006; 108(5):271-276.
doi: 10.1002/cncr.22167 pmid: 16948127
[17] Long HJ 3rd, Laack NN, Gostout BS . Prevention, diagnosis ,and treatment of cervical cancer. Mayo Clin Proc. 2007; 82(12):1566-1574.
doi: 10.1016/S0025-6196(11)61104-X pmid: 18053467
[18] Kalliala I, Nieminen P, Dyba T , et al. Cancer free survival after CIN treatment: comparisons of treatment methods and histology. Gynecol Oncol. 2007; 105(1):228-233.
doi: 10.1016/j.ygyno.2006.12.028 pmid: 17289128
[19] Canis M, Farina M, Jardon K , et al. Laparoscopy and gynecologic cancer in 2005. J Gynecol Obstet Biol Reprod (Paris). 2006; 35(2):117-135.
doi: 10.1016/S0368-2315(06)76386-4
[20] Cuzick J, Clavel C, Petry KU , et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006; 119(5):1095-1101.
[21] McCaffery K, Waller J, Nazroo J , et al. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect. 2006; 82(2):169-174.
doi: 10.1136/sti.2005.016436 pmid: 16581749
[22] Zheng Y, Peng ZL, Lou JY , et al. Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction. Ai Zheng. 2006; 25(3):373-377. Chinese with abstract in English.
doi: 10.3321/j.issn:1000-467X.2006.03.024
郑莹, 彭芝兰, 楼江燕 , 等. 多重实时PCR对宫颈癌组织及SiHa细胞株HPV-16病毒存在状态的检测.癌症. 2006; 25(3):373-377.
doi: 10.3321/j.issn:1000-467X.2006.03.024
[23] Dimopoulos JC, Schard G, Berger D , et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys. 2006; 64(5):1380-1388.
[24] Chung HH, Kim SK, Kim TH , et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: From diagnosis to prognosis. Gynecol Oncol. 2006; 103(1):165-170.
doi: 10.1016/j.ygyno.2006.02.016
[25] Falkenberg E, Kim RY, Meleth S , et al. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Brachytherapy. 2006 ; 5(1):49-55.
doi: 10.1016/j.brachy.2005.12.001
[26] Gerszten K, Colonello K, Heron DE , et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol. 2006; 102(2):182-188.
doi: 10.1016/j.ygyno.2005.12.044
[27] Nakano T, Suzuki Y, Ohno T , et al. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res. 2006; 12(7 parti):2185-2190.
doi: 10.1158/1078-0432.CCR-05-1907
[28] Lee KH, Yim EK, Kim CJ , et al. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol. 2005; 98(1) : 45-53.
doi: 10.1016/j.ygyno.2005.04.010 pmid: 15907983
[29] Ohno T, Kato S, Wakatsuki M , et al. Incidence and temporal pattern of anorexia,diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: Comparison with radiation therapy alone. Gynecol Oncol. 2006; 103(1):94-99.
doi: 10.1016/j.ygyno.2006.01.048
[30] Potter R, Dimopoulos J, Bachtiary B , et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol. 2006; 79(1):80-86.
doi: 10.1016/j.radonc.2006.01.007
[31] Tanaka T, Bai T, Yukawa K , et al. Optimal combination chemotherapy and chemoradiotherapy with etopo- side for advanced cervical squamous cancer cells in vitro. Oncol Rep. 2006; 15(4):939-947.
[32] Wong YF, Selvanayagam ZE, Wei N , et al. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res. 2003; 9(15):5486-5492.
[33] Zhang Z, Huettner PC, Nguyen L , et al. Aberrant promoter methylation and silencing of the FOU2F3 gene in cervical cancer. Oncogene. 2006; 25(39) : 5436-5445.
doi: 10.1038/sj.onc.1209530 pmid: 16607278
[34] Huang FY, Chiu PM, Tam KF , et al. Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer. Gynecol Oncol. 2006; 103(1):219-225.
doi: 10.1016/j.ygyno.2006.02.028
[35] Ueda M, Terai Y, Kanda K , et al. Fas gene promoter- 670 polymorphism in gynecological cancer. Int J Gynecol Cancer. 2006; 16 Suppl 1: 179-182.
doi: 10.1111/j.1525-1438.2006.00505.x pmid: 16515587
[36] Yim EK, Park JS . Role of proteomics in translational research in cervical cancer. Expert Rev Proteomics. 2006; 3(1):21-36.
doi: 10.1586/14789450.3.1.21 pmid: 16445348
[37] Feng YH, Li X , Wang et al. A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem. 2006; 281(25):17228-17237.
doi: 10.1074/jbc.M602999200
[38] Bae SM, Lee CH, Cho YL , et al. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol. 2005; 99(1):26-35.
doi: 10.1016/j.ygyno.2005.05.041 pmid: 16051329
[39] Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S , et al. Cyclin Al promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer. 2006; 6:55.
doi: 10.1186/1471-2407-6-55 pmid: 1435765
[40] Zhao M, Kim YT, Yoon BS , et al. Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol. 2006; 28(1):44-48.
doi: 10.1016/S0168-8278(01)00079-4 pmid: 16614707
[41] Li HY, Xu Q, Zhu T, et al. Expression and clinical significance of Pinl and Cyclin D1 in cervical cancer cell lines and cervical epithelial tissues. Ai Zheng. 2006; 25(3):367-372. Chinese with abstract in Engliah.
doi: 10.3969/j.issn.1000-467X.2006.03.023
李红雨, 徐茜, 朱涛 , 等. 宫颈癌细胞株和宫颈上皮组织中Pinl和Cyclin D1的表达及临床意义.癌症. 2006; 25(3):367-372.
doi: 10.3969/j.issn.1000-467X.2006.03.023
[42] Malinowski DP . Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high- grade cervical disease. Biotechniques. 2005
( Suppl):17-23.
[43] Gupta N, Martin PM, Miyauchi S , et al. Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem Biophys Res Commun. 2006; 343(2):571-577.
doi: 10.1016/j.bbrc.2006.02.172 pmid: 16554028
[44] Wu SH, Zhang J, Li Y , et al. Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis. Ai Zheng. 2006; 25(3):315-319. Chinese with abstract in English.
吴素慧, 张静, 李颖 , 等. ETV5对MMP-7在早期宫颈癌组织中的表达及其在转移中的作用.癌症. 2006; 25(3):315-319.
[45] Branca M, Ciotti M, Giorgi C , et al. Matrix metallo- proteinase-2 (MMP-2) and its tissue inhibitor (TIMP- 2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN. Anticancer Res. 2006; 26(2B):1543-1556.
[46] Branca M, Giorgi C, Ciotti M , et al. Down-regulated nucleoside diphosphate kinase nm23_Hl expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer. J Clin Pathol. 2006; 59(10):1044-1051.
[47] Divya CS, Pillai MR . Antitumor action of curcumin in human papillomavirus associated cells involves downreg- ulation of viral oncogenes, prevention of NF-κB and AP- 1 translocation, and modulation of apoptosis. MolCar- cinog. 2006; 45(5):320-332.
[48] Kim SH, Hwang Cl, Juhnn YS , et al. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis. 2007; 28(1) : 223-231.
doi: 10.1093/carcin/bgl227 pmid: 3222217166886
[49] Putral LN, Bywater MJ, Gu W , et al. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol Pharmacol. 2005; 68(5):1311-1319.
doi: 10.1124/mol.105.014191
[50] Niu XY, Peng ZL, Duan WQ, et al. Inhibition of HPVI6 E6 oncogene in cervical cancer by RNA interference. Sichuan Da Xue Xue Bao ( Yi Xue Ban ). 2006; 37(1):14-18. Chinese with abstract in English.
牛晓宇, 彭芝兰, 段伟强 , 等. RNA干涉抑制宫颈癌 HPV16E6基因的研究. 四川大学学报(医学版). 2006; 37(1):14-18.
[51] Tang S, Tao M , McCoy JP Jr, et al. Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene. 2006; 25(14):2094-2104.
doi: 10.1038/sj.onc.1209244
[52] Vogt M, Butz K, Dymalla S , et al. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene. 2006; 25(29):4009-4015.
doi: 10.1038/sj.onc.1209429
[53] Li W, Jian W, Xiaoping X , et al. Enhanced radiation- mediated cell killing of human cervical cancer cells by small interference RNA silencing of ataxia telangiectasia-mutated protein. Int J Gynecol Cancer. 2006; 16(4):1620-1630.
[54] Rossi A, Ciafre S, Balsamo M , et al. Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res. 2006; 66(15) : 7678-7685.
doi: 10.1158/0008-5472.CAN-05-4282
[55] Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-866.
doi: 10.1038/nrc1997 pmid: 17060945
[56] Cho WC . OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007; 6(1) : 60.
doi: 10.1186/1476-4598-6-60
[57] Lui WO, Pourmand N, Patterson BK , et al. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007; 67(13):6031-6043.
doi: 10.1158/0008-5472.CAN-06-0561
[1] Louisa Sylvia, Emerson West, Allyson M. Blackburn, Carina Gupta, Eric Bui, Tara Mahoney, Geraldine Duncan, Edward C. Wright, Simon Lejeune, Thomas J. Spencer. Acceptability of an adjunct equine-assisted activities and therapies program for veterans with posttraumatic stress disorder and/or traumatic brain injury. Journal of Integrative Medicine, 2020, 18(2): 169-173.
[2] Rebecca Kulbida, Alexander Mathes, Johannes Loeser. Beneficial effects of hirudotherapy in a chronic case of complex regional pain syndrome. Journal of Integrative Medicine, 2019, 17(5): 383-386.
[3] Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[4] Charles Dalcanale Tesser, Ari Ojeda Ocampo Moré, Melissa Costa Santos, Emiliana Domingues Cunha da Silva, Fátima Terezinha Pelachini Farias, Lúcio José Botelho. Auriculotherapy in primary health care: A large-scale educational experience in Brazil. Journal of Integrative Medicine, 2019, 17(4): 302-309.
[5] L. Elisabeth Burton, Fares Qeadan, Mark R. Burge. Efficacy of equine-assisted psychotherapy in veterans with posttraumatic stress disorder. Journal of Integrative Medicine, 2019, 17(1): 14-19.
[6] Jillian Marie McDowell, Susan Heather Kohut, Debra Betts . Safe acupuncture and dry needling during pregnancy: New Zealand physiotherapists’ opinion and practice. Journal of Integrative Medicine, 2019, 17(1): 30-37.
[7] Syed Nasir Abbas Bukhari, Fahad Hussain, Hnin Ei Thu, Zahid Hussain. Synergistic effects of combined therapy of curcumin and Fructus Ligustri Lucidi for treatment of osteoporosis: cellular and molecular evidence of enhanced bone formation. Journal of Integrative Medicine, 2019, 17(1): 38-45.
[8] Ralph Fernando Rosas, Aline Armiliato Emer, Ana Paula Batisti, Daniela Dero Ludtke, Bruna Lenfers Turnes, Franciane Bobinski, Francisco José Cidral-Filho, Daniel Fernandes Martins. Far infrared-emitting ceramics decrease Freund’s adjuvant-induced inflammatory hyperalgesia in mice through cytokine modulation and activation of peripheral inhibitory neuroreceptors. Journal of Integrative Medicine, 2018, 16(6): 396-403.
[9] Ioannis Solos, Yuan Liang. A historical evaluation of Chinese tongue diagnosis in the treatment of septicemic plague in the pre-antibiotic era, and as a new direction for revolutionary clinical research applications. Journal of Integrative Medicine, 2018, 16(3): 141-146.
[10] Sepideh Hamdamian, Soheila Nazarpour, Masoumeh Simbar, Sepideh Hajian, Faraz Mojab, AtefehTalebi. Effects of aromatherapy with Rosa damascena on nulliparous women’s pain and anxiety of labor during first stage of labor. Journal of Integrative Medicine, 2018, 16(2): 120-125.
[11] Shahnaz Karkon Varnosfaderani, Fataneh Hashem-Dabaghian, Gholamreza Amin, Mahbubeh Bozorgi, Ghazaleh Heydarirad, Esmaeil Nazem, Mohsen Nasiri Toosi, Seyed Hamdollah Mosavat. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: A double-blind, randomized, placebo-controlled clinical trial. Journal of Integrative Medicine, 2018, 16(2): 126-131.
[12] Xuan Liu, Li-juan Xiu, Jian-peng Jiao, Jing Zhao, Ying Zhao, Ye Lu, Jun Shi, Yong-jin Li, Min Ye, Yu-fang Gu, Xiao-wei Wang, Jing-yu Xu, Ci-an Zhang, Yong-ying Liu, Yun Luo, Xiao-qiang Yue. Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: A retrospective clinical analysis. Journal of Integrative Medicine, 2017, 15(6): 469-475.
[13] Bruno Bordoni, Fabiola Marelli, Bruno Morabito, Beatrice Sacconi. The indeterminable resilience of the fascial system. Journal of Integrative Medicine, 2017, 15(5): 337-343.
[14] Ali Ramazan Benli, Habibullah Aktas. A complication of wet cupping therapy: Vesiculobullous plaque on an erythematous base. Journal of Integrative Medicine, 2017, 15(3): 252-254.
[15] Marco Cascella, Maria Rosaria Muzio. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy. Journal of Integrative Medicine, 2017, 15(2): 77-87.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[3] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[4] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[5] Ming-qing Wei , Jin-zhou Tian , Jing Shi , Fu-yun Ma , Ying-chun Miao , Yong-yan Wang. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(11): 1240-1246
[6] Nian-hong Wang , Jun-tao Yan , Wu-quan Sun , Yong-shan Hu , Jun Xia , Li-cheng Wei , Jie Jia , Gui-lin Ouyang , Yong He , Yan-ming Guo , Jie Xu . Effects of early application of Tuina treatment on quadriceps surface myoelectricity in patients after total knee arthroplasty: a randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(11): 1247-1253
[7] Veena Sharma , Pracheta Janmeda , Ritu Paliwal , Shatruhan Sharma. Antihepatotoxic activity of Euphorbia neriifolia extract against N-nitrosodiethylamine-induced hepatocarcinogenesis in mice. Journal of Chinese Integrative Medicine, 2012, 10(11): 1303-1309
[8] Zhao-guo Li , Rui-qiang Liu. Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases in Internal Medicine (Part 7). Journal of Chinese Integrative Medicine, 2012, 10(11): 1310-1315
[9] Peng-fei Gao, Kenji Watanabe. Introduction of the World Health Organization project of the International Classification of Traditional Medicine. Journal of Chinese Integrative Medicine, 2011, 9(11): 1161-1164
[10] Kishan Lal Tiwari, Shailesh Kumar Jadhav, Veenu Joshi. An updated review on medicinal herb genus Spilanthes. Journal of Chinese Integrative Medicine, 2011, 9(11): 1170-1178